Advisor Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-3,998
| Closed | -$734K | – | 861 |
|
|
2021
Q2 | $734K | Sell |
3,998
-56
| -1% | -$10.3K | 0.05% | 378 |
|
|
2021
Q1 | $620K | Buy |
4,054
+50
| +1% | +$7.65K | 0.04% | 416 |
|
|
2020
Q4 | $626K | Buy |
4,004
+139
| +4% | +$21.7K | 0.05% | 382 |
|
|
2020
Q3 | $442K | Sell |
3,865
-93
| -2% | -$10.6K | 0.04% | 428 |
|
|
2020
Q2 | $444K | Buy |
3,958
+1,236
| +45% | +$139K | 0.04% | 398 |
|
|
2020
Q1 | $244K | Buy |
2,722
+894
| +49% | +$80.1K | 0.03% | 493 |
|
|
2019
Q4 | $206K | Buy |
+1,828
| New | +$206K | 0.02% | 597 |
|
|
2019
Q3 | – | Sell |
-2,338
| Closed | -$306K | – | 693 |
|
|
2019
Q2 | $306K | Sell |
2,338
-44
| -2% | -$5.76K | 0.04% | 455 |
|
|
2019
Q1 | $322K | Buy |
2,382
+291
| +14% | +$39.3K | 0.04% | 418 |
|
|
2018
Q4 | $204K | Sell |
2,091
-1,406
| -40% | -$137K | 0.03% | 545 |
|
|
2018
Q3 | $486K | Buy |
3,497
+391
| +13% | +$54.3K | 0.07% | 309 |
|
|
2018
Q2 | $386K | Buy |
3,106
+328
| +12% | +$40.8K | 0.07% | 349 |
|
|
2018
Q1 | $310K | Buy |
2,778
+433
| +18% | +$48.3K | 0.06% | 379 |
|
|
2017
Q4 | $284K | Sell |
2,345
-802
| -25% | -$97.1K | 0.05% | 420 |
|
|
2017
Q3 | $441K | Buy |
3,147
+1,426
| +83% | +$200K | 0.09% | 259 |
|
|
2017
Q2 | $209K | Sell |
1,721
-954
| -36% | -$116K | 0.05% | 434 |
|
|
2017
Q1 | $324K | Sell |
2,675
-157
| -6% | -$19K | 0.09% | 300 |
|
|
2016
Q4 | $346K | Buy |
+2,832
| New | +$346K | 0.1% | 246 |
|
|
2016
Q1 | – | Sell |
-1,795
| Closed | -$342K | – | 422 |
|
|
2015
Q4 | $342K | Buy |
1,795
+204
| +13% | +$38.9K | 0.12% | 185 |
|
|
2015
Q3 | $249K | Sell |
1,591
-411
| -21% | -$64.3K | 0.1% | 233 |
|
|
2015
Q2 | $350K | Buy |
2,002
+354
| +21% | +$61.9K | 0.13% | 199 |
|
|
2015
Q1 | $286K | Buy |
1,648
+1
| +0.1% | +$174 | 0.12% | 226 |
|
|
2014
Q4 | $305K | Buy |
1,647
+217
| +15% | +$40.2K | 0.13% | 204 |
|
|
2014
Q3 | $237K | Buy |
1,430
+30
| +2% | +$4.97K | 0.14% | 195 |
|
|
2014
Q2 | $219K | Buy |
+1,400
| New | +$219K | 0.11% | 249 |
|